PharmExec Direct eNewsletter

PharmExec Direct:
Having trouble viewing this e-mail? Click here.

You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile

PharmExec Direct | From the editors of Pharmaceutical Executive

December 16, 2010 | ISSUE NUMBER 179 VOL 8

Global
US and China Pharma Relations at a Crossroads
The traditional innovator drug model that has served pharma well in Western markets will not be the model for success in China’s market.

Legal
Federal Judge Declares Mandatory Health Insurance Unconstitutional
A showdown is on the horizon between Congress, President Obama, and the Supreme Court over the legality of this year’s health reform legislation.

Work Force
Work Shortage in Oncology Imminent
Supply and demand for oncology specialists is expected to become even more unbalanced in the US market.

Europe
End of an EMA Era
The European Medicines Agency’s outgoing Executive Director Thomas Lönngren talks to Pharm Exec.

Pharma Advertising
What Was Your Favorite Pharma Ad of 2010?
Pharm Exec has begun its search for the Ad Stars, our annual feature honoring the best in Rx advertising—and we want your input!

		Automated Contracts & ChargeBacks help you grow from clinical trials into full scale production. Get the steps to rapidly streamlining production and increasing cash flow, while minimizing compliance risk. Discover how an integrated ERP solution with automated CCB from CDC Software has helped Aurobindo reduce its processing times by over 80% and helped RxElite save hundreds of thousands of dollars.Click here

// Dan Schwartz joined Advanstar Communications as Director of Editorial for the Healthcare Group, based in the North Olmsted (Ohio) office. // ERT (Philadelphia), a technology and services provider, announced the appointment of Klaus Besier to its Board of Directors. // Sutro Biopharma (San Francisco), a biopharmaceutical company, appointed Trevor Hallam, PhD., as Chief Scientific Officer. //

Jan 11–12: The State of Clinical Development Costs
Philadelphia, PA

Jan 24–25: 8th Annual Pharmaceutical Compliance Congress
Washington, DC

Feb 7-9: 2nd Annual Cloud Computing for DoD & Government
Vienna, VA

Who do you think will become the most influential healthcare stakeholders in the next few years?

A Changing of the Pharma Guard

EU’s Health Commissioner Emerges from the Dark

Sanofi and Genzyme at Impasse


	Follow Pharm Exec on Twitter
	Follow Pharm Exec on Facebook

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.